MedTrace Logo

Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy

NCT05059691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2023-05-15

No results posted yet for this study

Summary

This study assesses the effectiveness of transbronchial cryobiopsy guided by 3-dimensional fluoroscopy. Transbronchial cryobiopsy is a procedure to collect lung tissue. The main side effect seen after a transbronchial cryobiopsy is pneumothorax (air leaking out of the lung, which may cause a completely or partially collapsed lung). The standard imaging scans used during this procedure are 2-dimensional (like a photo), which can make it difficult for the doctor to know exactly where the biopsy tool is during the procedure. If the exact location of the device is not clear, a patient can be at a higher risk of pneumothorax. Using a 3-dimensional imaging technique may help to decrease the risk of pneumothorax during transbronchial cryobiopsy.

Conditions

  • Lung Carcinoma

Interventions

OTHER

Electronic Health Record Review

Review of medical records

PROCEDURE

Transbronchial Cryobiopsy Guided by Three-Dimensional Fluoroscopy

Undergo transbronchial cryobiopsy guided by three-dimensional fluoroscopy

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Bruce F Sabath · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-30
Primary Completion
2023-05-11
Completion
2023-05-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05059691 on ClinicalTrials.gov